Some individuals carrying these mutations have been reported with clinical manifestations indistinguishable from AD [20]–[28], but the frequency of mutations in GRN and MAPT in clinical series of LOAD cases is unknown. The gene discussed is GRN; the disease is Alzheimer disease.